Last reviewed: July 1, 2026

Last updated: July 1, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide dosing is not a one-size-fits-all approach—most patients begin at a low starting dose and gradually increase over 16–20 weeks to reach their optimal therapeutic level. Understanding how your dose is measured and adjusted ensures you get the maximum benefit while minimizing nausea and other common side effects. PlexusDx delivers compounded semaglutide injections through licensed 503A pharmacies with flat monthly pricing that never changes as your dose climbs.

Understanding Semaglutide Dose Measurement in Milligrams

Semaglutide dose is measured in milligrams (mg) per injection, not per kilogram of body weight. The standard clinical escalation protocol begins at 0.25 mg once weekly, then increases by 0.25 mg increments every four weeks until reaching a maintenance dose of 1.0 mg or 2.4 mg per week, depending on your treatment goals and tolerance. This stepwise approach mirrors the successful dosing strategy used in major weight loss trials, where gradual escalation reduced gastrointestinal side effects by up to 40% compared to rapid dose advancement.

Each semaglutide injection contains a specific concentration dissolved in a prefilled pen or vial, allowing for precise weekly administration. PlexusDx compounds semaglutide in concentrations that match your prescribed dose, eliminating guesswork and ensuring consistency from week to week. Your healthcare provider determines the exact milligram dose based on your baseline weight, metabolic profile, and how your body responds to earlier dose increments.

The Four-Week Dose Escalation Schedule Explained

The standard semaglutide titration schedule spans 16 weeks for patients targeting a 1.0 mg weekly maintenance dose, or 20 weeks for those pursuing the 2.4 mg dose. Weeks 1–4 use 0.25 mg, weeks 5–8 advance to 0.5 mg, weeks 9–12 reach 0.75 mg, and weeks 13–16 settle at 1.0 mg. If continuing to 2.4 mg, weeks 17–20 increment to 1.7 mg then 2.4 mg. This measured progression allows your digestive system to adapt, reducing nausea and vomiting that occur when doses increase too rapidly.

Delaying dose escalation by an extra week or two is safe and common when patients experience mild side effects—your doctor can pause at any step without restarting the sequence. Real-world data shows that approximately 15–20% of patients extend their titration by 2–4 weeks to optimize tolerability. PlexusDx coordinates with your provider to track your dose adjustments and ensures your monthly price remains constant regardless of whether you're at week 4 or week 20 of your escalation plan.

Why Your Dose May Increase but Your Price Won't

PlexusDx compounded semaglutide injections start at $149 per month and remain flat across all commitment tiers—your dose may increase, but your monthly cost stays exactly the same. Unlike insurance plans or pharmacy chains that charge based on dose strength, PlexusDx separates dosing decisions from pricing, removing financial barriers to optimal treatment. This pricing structure means you can confidently escalate to 1.0 mg or 2.4 mg without worrying about surprise billing or higher monthly premiums.

Compounding through licensed 503A pharmacies allows PlexusDx to offer this flat-rate model while maintaining pharmaceutical-grade quality and safety standards. Your monthly subscription covers any dose level within your prescribed range, from your initial 0.25 mg injection through your target maintenance dose. HSA and FSA accounts are accepted, making semaglutide therapy more accessible for patients managing their healthcare spending.

Measuring Your Response: Weight Loss and Metabolic Markers

Measuring semaglutide success involves tracking more than just the dose itself—your actual weight loss, appetite suppression, and blood glucose control are the true indicators of efficacy. Clinical trials show that patients reaching 1.0 mg weekly lose 8–10% of body weight over 12 weeks, while those reaching 2.4 mg average 15–17% weight loss over the same period. PlexusDx recommends weekly weigh-ins and monthly lab work measuring fasting glucose, HbA1c, and lipid panels to confirm your dose is delivering metabolic improvement.

Your provider may also evaluate whether increasing your dose further is necessary based on your response plateau—some patients achieve their weight loss goal at 0.75 mg, while others benefit from the full 2.4 mg dose. Tracking non-scale victories like improved energy, reduced cravings, and smaller portion sizes helps contextualize dose adjustments beyond pure kilogram loss. The Precision Peptide Genetic Test available through PlexusDx for $99 after your first month identifies genetic variants in GLP1R and other peptide pathways that predict whether you're likely a responder to standard or higher semaglutide doses.

Storage, Handling, and Measuring Accuracy at Home

Proper storage of compounded semaglutide ensures dose accuracy and medication stability—vials and pens must be refrigerated at 2–8°C (36–46°F) before first use and can be stored at room temperature (below 30°C) for up to 30 days after opening. Measuring your dose accurately depends on using the correct syringe gauge (typically 29–31 gauge insulin syringes for injections) and following your provider's written dose instructions precisely. PlexusDx includes detailed administration guides with every shipment, and our patient support team is available to clarify dosing questions before your first injection.

Never measure semaglutide by guesswork or visual estimation—using the wrong syringe size or eyeballing your dose can result in underdosing (reducing efficacy) or overdosing (increasing side effects). Write down your weekly dose on a calendar, initial it after each injection, and report any missed doses or injection concerns to your provider immediately. Keeping a simple log also helps your doctor assess whether dose escalation is proceeding safely and whether side effects are manageable at your current level.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

What is the starting semaglutide dose, and when does it increase?

The standard starting dose is 0.25 mg once weekly, with increases of 0.25 mg every four weeks until reaching your target maintenance dose of 1.0 mg or 2.4 mg. PlexusDx coordinates timing with your provider to ensure safe, predictable dose escalation without monthly price changes.

How does the semaglutide dose escalation schedule reduce side effects?

Gradual dose increases allow your GI system to adapt, reducing nausea and vomiting by up to 40% compared to rapid escalation. Clinical trials confirm that four-week intervals between dose bumps optimize tolerability while maintaining weight loss effectiveness.

Does PlexusDx charge different prices for different semaglutide doses?

No—PlexusDx compounded semaglutide injections start at $149 per month and remain flat regardless of whether you're taking 0.25 mg or 2.4 mg weekly. Your dose may increase, but your price won't.

What if I experience side effects during dose escalation?

Your provider can pause dose escalation, extend the four-week interval, or reduce your dose temporarily—all without changing your monthly PlexusDx subscription price. Mild side effects typically resolve within 1–2 weeks as your body adapts.

Can the Precision Peptide Genetic Test predict my ideal semaglutide dose?

The Precision Peptide Genetic Test ($99 after month one) identifies variants in GLP1R, GIPR, FTO, and MC4R genes that influence your peptide pathway sensitivity, helping predict whether you'll respond optimally to standard or higher semaglutide doses. This genetic insight personalizes your treatment plan beyond population averages.

Related Reading

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves